Report Detail

Request for Sample of this report

Pharma & Healthcare Global Rituximab Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4744932
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 142 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Rituximab Injection market size was valued at US$ 2788 million in 2025 and is forecast to a readjusted size of US$ 9704 million by 2032 with a CAGR of 19.7% during review period.
Rituximab injection sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.
This report is a detailed and comprehensive analysis for global Rituximab Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Rituximab Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Rituximab Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Rituximab Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Rituximab Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rituximab Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rituximab Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Amgen, Roche, Celltrion, Innovent Biologics, Intas Pharmaceuticals, Shanghai Henlius Biotech, Fosun-Pharmaceutical, Lexicare Pharma, Healthiza Lifescience, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Rituximab Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100 ml
500 ml
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Pfizer
Amgen
Roche
Celltrion
Innovent Biologics
Intas Pharmaceuticals
Shanghai Henlius Biotech
Fosun-Pharmaceutical
Lexicare Pharma
Healthiza Lifescience
Kavya Pharma
Cadila Pharmaceuticals
Dr Reddy’s Laboratories
Hetero Group
Probiomed
TRPharma
Zenotech Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rituximab Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rituximab Injection, with price, sales quantity, revenue, and global market share of Rituximab Injection from 2021 to 2026.
Chapter 3, the Rituximab Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rituximab Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Rituximab Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rituximab Injection.
Chapter 14 and 15, to describe Rituximab Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Rituximab Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 100 ml
    • 1.3.3 500 ml
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Rituximab Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Rituximab Injection Market Size & Forecast
    • 1.5.1 Global Rituximab Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Rituximab Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Rituximab Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Rituximab Injection Product and Services
    • 2.1.4 Pfizer Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Amgen
    • 2.2.1 Amgen Details
    • 2.2.2 Amgen Major Business
    • 2.2.3 Amgen Rituximab Injection Product and Services
    • 2.2.4 Amgen Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Amgen Recent Developments/Updates
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Rituximab Injection Product and Services
    • 2.3.4 Roche Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Roche Recent Developments/Updates
  • 2.4 Celltrion
    • 2.4.1 Celltrion Details
    • 2.4.2 Celltrion Major Business
    • 2.4.3 Celltrion Rituximab Injection Product and Services
    • 2.4.4 Celltrion Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Celltrion Recent Developments/Updates
  • 2.5 Innovent Biologics
    • 2.5.1 Innovent Biologics Details
    • 2.5.2 Innovent Biologics Major Business
    • 2.5.3 Innovent Biologics Rituximab Injection Product and Services
    • 2.5.4 Innovent Biologics Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Innovent Biologics Recent Developments/Updates
  • 2.6 Intas Pharmaceuticals
    • 2.6.1 Intas Pharmaceuticals Details
    • 2.6.2 Intas Pharmaceuticals Major Business
    • 2.6.3 Intas Pharmaceuticals Rituximab Injection Product and Services
    • 2.6.4 Intas Pharmaceuticals Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Intas Pharmaceuticals Recent Developments/Updates
  • 2.7 Shanghai Henlius Biotech
    • 2.7.1 Shanghai Henlius Biotech Details
    • 2.7.2 Shanghai Henlius Biotech Major Business
    • 2.7.3 Shanghai Henlius Biotech Rituximab Injection Product and Services
    • 2.7.4 Shanghai Henlius Biotech Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Shanghai Henlius Biotech Recent Developments/Updates
  • 2.8 Fosun-Pharmaceutical
    • 2.8.1 Fosun-Pharmaceutical Details
    • 2.8.2 Fosun-Pharmaceutical Major Business
    • 2.8.3 Fosun-Pharmaceutical Rituximab Injection Product and Services
    • 2.8.4 Fosun-Pharmaceutical Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Fosun-Pharmaceutical Recent Developments/Updates
  • 2.9 Lexicare Pharma
    • 2.9.1 Lexicare Pharma Details
    • 2.9.2 Lexicare Pharma Major Business
    • 2.9.3 Lexicare Pharma Rituximab Injection Product and Services
    • 2.9.4 Lexicare Pharma Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Lexicare Pharma Recent Developments/Updates
  • 2.10 Healthiza Lifescience
    • 2.10.1 Healthiza Lifescience Details
    • 2.10.2 Healthiza Lifescience Major Business
    • 2.10.3 Healthiza Lifescience Rituximab Injection Product and Services
    • 2.10.4 Healthiza Lifescience Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Healthiza Lifescience Recent Developments/Updates
  • 2.11 Kavya Pharma
    • 2.11.1 Kavya Pharma Details
    • 2.11.2 Kavya Pharma Major Business
    • 2.11.3 Kavya Pharma Rituximab Injection Product and Services
    • 2.11.4 Kavya Pharma Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Kavya Pharma Recent Developments/Updates
  • 2.12 Cadila Pharmaceuticals
    • 2.12.1 Cadila Pharmaceuticals Details
    • 2.12.2 Cadila Pharmaceuticals Major Business
    • 2.12.3 Cadila Pharmaceuticals Rituximab Injection Product and Services
    • 2.12.4 Cadila Pharmaceuticals Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Cadila Pharmaceuticals Recent Developments/Updates
  • 2.13 Dr Reddy’s Laboratories
    • 2.13.1 Dr Reddy’s Laboratories Details
    • 2.13.2 Dr Reddy’s Laboratories Major Business
    • 2.13.3 Dr Reddy’s Laboratories Rituximab Injection Product and Services
    • 2.13.4 Dr Reddy’s Laboratories Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Dr Reddy’s Laboratories Recent Developments/Updates
  • 2.14 Hetero Group
    • 2.14.1 Hetero Group Details
    • 2.14.2 Hetero Group Major Business
    • 2.14.3 Hetero Group Rituximab Injection Product and Services
    • 2.14.4 Hetero Group Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Hetero Group Recent Developments/Updates
  • 2.15 Probiomed
    • 2.15.1 Probiomed Details
    • 2.15.2 Probiomed Major Business
    • 2.15.3 Probiomed Rituximab Injection Product and Services
    • 2.15.4 Probiomed Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Probiomed Recent Developments/Updates
  • 2.16 TRPharma
    • 2.16.1 TRPharma Details
    • 2.16.2 TRPharma Major Business
    • 2.16.3 TRPharma Rituximab Injection Product and Services
    • 2.16.4 TRPharma Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 TRPharma Recent Developments/Updates
  • 2.17 Zenotech Laboratories
    • 2.17.1 Zenotech Laboratories Details
    • 2.17.2 Zenotech Laboratories Major Business
    • 2.17.3 Zenotech Laboratories Rituximab Injection Product and Services
    • 2.17.4 Zenotech Laboratories Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Zenotech Laboratories Recent Developments/Updates

3 Competitive Environment: Rituximab Injection by Manufacturer

  • 3.1 Global Rituximab Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Rituximab Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Rituximab Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Rituximab Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Rituximab Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Rituximab Injection Manufacturer Market Share in 2025
  • 3.5 Rituximab Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Rituximab Injection Market: Region Footprint
    • 3.5.2 Rituximab Injection Market: Company Product Type Footprint
    • 3.5.3 Rituximab Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Rituximab Injection Market Size by Region
    • 4.1.1 Global Rituximab Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Rituximab Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Rituximab Injection Average Price by Region (2021-2032)
  • 4.2 North America Rituximab Injection Consumption Value (2021-2032)
  • 4.3 Europe Rituximab Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Rituximab Injection Consumption Value (2021-2032)
  • 4.5 South America Rituximab Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Rituximab Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Rituximab Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Rituximab Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Rituximab Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Rituximab Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Rituximab Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Rituximab Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Rituximab Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Rituximab Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Rituximab Injection Market Size by Country
    • 7.3.1 North America Rituximab Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Rituximab Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Rituximab Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Rituximab Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Rituximab Injection Market Size by Country
    • 8.3.1 Europe Rituximab Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Rituximab Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Rituximab Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Rituximab Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Rituximab Injection Market Size by Region
    • 9.3.1 Asia-Pacific Rituximab Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Rituximab Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Rituximab Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Rituximab Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Rituximab Injection Market Size by Country
    • 10.3.1 South America Rituximab Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Rituximab Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Rituximab Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Rituximab Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Rituximab Injection Market Size by Country
    • 11.3.1 Middle East & Africa Rituximab Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Rituximab Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Rituximab Injection Market Drivers
  • 12.2 Rituximab Injection Market Restraints
  • 12.3 Rituximab Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Rituximab Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Rituximab Injection
  • 13.3 Rituximab Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Rituximab Injection Typical Distributors
  • 14.3 Rituximab Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Rituximab Injection. Industry analysis & Market Report on Rituximab Injection is a syndicated market report, published as Global Rituximab Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Rituximab Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo